Biotech company Snipr Biome has found a partner to help develop new treatments using CRISPR technology, which targets the human microbiome.
The company has teamed up with renowned US cancer hospital MD Anderson Cancer Center, which is associated with the University of Texas. Snipr Biome will work with a research department at the hospital called PRIME-TR.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.